German Merck Q4 Profit Falls but Outlook Brightens

Fourth-quarter earnings at German drug and chemical maker Merck KGaA were down 18 percent due to the effect of deferred tax assets, but the company cheered investors on Monday by issuing an upbeat forecast for this year and next.
CNBC